The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 2.05 — grey zone — between safe and distressedWatch
- Earnings-manipulation signal · Beneish M -2.79 — no flag raisedOK
- Earnings quality 100/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as Pediatrix Medical Group, Inc. reports it. History and quarterly detail are in the app.
- Health Care Patient Service$1.6B
- Hospitals Contracts$271.1M
- Product And Service Other$12.2M
Leadership changes
From Pediatrix Medical Group, Inc.'s own filings, the day they're filed.
- Kurt Newman · Director · appointmenteff. 2025-07-01
- Mark S. Ordan · Chief Executive Officer · appointment
- Employment Period · departure
Latest filings
- 10-Q · Quarterly report2026-08-04
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-07-24
- 8-K · Company announcement2026-07-15
- 8-K · Company announcement2026-05-07
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Pediatrix Medical Group, Inc., every answer cited to the official filings🔒
- The Intelligence Brief — added when Pediatrix Medical Group, Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.